Drawing for GIVE HEALING EVERY ADVANTAGE

USPTO serial 98978614

GIVE HEALING EVERY ADVANTAGE

Reviewed by CopyMark Law Group

Reg. 8414980Status 700Registered
Filing date
Status date
Registration date
Aug 25, 2026
Examiner
DELGIZZI, RONALD ERNEST
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GIVE HEALING EVERY ADVANTAGE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William Jackson Matney

William Jackson Matney Matney Legal Group PLLC1818 Library St, Suite 500Reston, VA 20190United States

Goods and services

ClassDescriptionStatusFirst use
001Cells for scientific, laboratory, and medical research use; Cell culture media for scientific, laboratory, and research use; biological tissue, namely, bone, blood, muscle, organ, skin and vascular tissue for scientific, laboratory, and medical research use; in vitro assays for scientific, laboratory, and medical research use; in vitro assays for drug research use; human cells, biological tissue being bone, blood, muscle, organ, skin and vascular tissue, and in vitro assays for scientific and medical research use for drug discovery and development applications, and toxicity research studiesACTIVE—
005Human allograft tissue and cells; biological bone, skin, placental, amnion, chorion, umbilical cord, tendons, cartilage, veins, arteries, heart valves, and cardiovascular tissues intended for subsequent implantation; human allograft tissue for use in vascular surgery and vascular treatment; human allograft tissue for orthopedic use; human allograft tissue for use in burn and wound treatment; human allograft tissue for use in treatment of musculoskeletal disorders and conditions; Cells for medical or clinical use; Cell growth media for growing cells for medical or clinical use; medical diagnostic reagents; Dressings and bandages for skin wounds; Wound healing system comprised of medical dressing and bandages for skin wounds; Medical dressings; Gauze for dressings; Burn dressings; Surgical dressings; Medical dressings for negative pressure wound therapy; Pharmaceutical preparations for wounds; Pharmaceutical preparations for dermatological conditions; Balms for pharmaceutical purposes; medical ointments for treating dermatological conditions, burns, pain and topical infections; Medicated lotions for body; Pharmaceutical preparations for skin care; Pharmaceutical preparations for pain relief; Antibiotics; anti-infectives; anti-fungal pharmaceutical preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 25, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 25, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 4, 2026SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 4, 2026CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 15, 2026DOCKASSIGNED TO EXAMINER—
Jul 2, 2026SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 2, 2026DPCCDIVISIONAL PROCESSING COMPLETE—
Jul 1, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 21, 2026AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 19, 2025IUAFUSE AMENDMENT FILED—
Nov 19, 2025DRRRDIVISIONAL REQUEST RECEIVED—
Nov 19, 2025ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Nov 19, 2025EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jul 8, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 7, 2025EX1GSOU EXTENSION 1 GRANTED—
Jul 7, 2025EXT1SOU EXTENSION 1 FILED—
Jul 7, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 26, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 26, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 20, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 29, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 28, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 28, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 28, 2024ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Jul 30, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jul 30, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Apr 30, 2024GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 30, 2024GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 30, 2024CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 29, 2024TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 29, 2024CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 29, 2024TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 5, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 5, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 5, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 5, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 26, 2024XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jan 26, 2024XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Oct 31, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 31, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 31, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 26, 2023DOCKASSIGNED TO EXAMINER—
Jun 29, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 2, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance